Is harm reduction funding in low and middle income countries in crisis? Susie McLean, International HIV/AIDS Alliance Catherine Cook, Harm Reduction International.

Slides:



Advertisements
Similar presentations
HIV and Harm Reduction Winning on policy front : Faltering on Implementation JVR Prasada Rao, UNAIDS XVIII International Harm Reduction Conference Warsaw,
Advertisements

SGA1 – The evolving role of UNAIDS in a changing financial environment UNAIDS has adapted to a new funding environment and developed strong and positive.
Global Fund Investments in Harm Reduction Washington, July 2012 Global Fund Investments for People Who Inject Drugs 23 July 2012 Professor Jeffrey V. Lazarus.
Taking Another Look at Condoms Patrick Friel Reproductive Health HIV/AIDS Consultancy 27 April 2006.
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
VIET NAM 5 th IHP+ Country Teams Meeting Session 4c: Middle income countries (MICs) On behalf of the Health Partnership Group.
NEW INVESTMENT FRAMEWORK FOR HIV/AIDS Making the Case in Botswana.
National HIV Investment Plan (NHIP) – a new wine in old bottle: a case from Nepal This study aims to examine the value addition, if any,
No money, no results! New estimates of need No money, no results! New estimates of need Carlos Avila and Catherine Hankins Joint United Nations Programme.
Slide 2 Key Points Although HIV/AIDS is found throughout the world, most people living with HIV/AIDS reside in low- and middle-income countries More people.
HIV and the Financial Crisis Academic Council Debate on the Financial Crisis and Public Health Robert Greener, April 30, 2009.
Budget support and managing for results Presentation by Bodo Ellmers Action for Global Health Roundtable Madrid, 7 June 2010.
Jennifer Kates, Kaiser Family Foundation Eric Lief, Center for Strategic and International Studies/UNAIDS July 2006 International Assistance for HIV/AIDS.
International HIV Assistance from Donor Governments: Commitments & Disbursements, US$ Billions Commitments (Enacted Amounts) Disbursements SOURCES:
HIV/AIDS Webinar Statistics and Monitoring Tessa Wardlaw Statistics & Monitoring Section/Policy & Practice 20 October 2010.
Teresa Guthrie M.PH (Health Economics) HIV modelling for in-country ownership solutions – generation of evidence IAS Conference, Washington DC, July.
Performance Monitoring and Financial Reports Performance Monitoring and Financial Reports UNAIDS and Unified Budget and Workplan (UBW)
‘More Than Just Lip Service: Scaling up sex work initiatives’ Making the Money Matter: Support for sex worker initiatives through the Global Fund for HIV,
HIV/AIDS: A Global and Regional Perspective AIDS in Post 2015 Development Agenda.
Tracking Expenditure for HIV and AIDS in Africa ~ Cross-Country Comparisons Guthrie, T., Kioko, U. Inaugural Conference of the African Health Economics.
Injecting Drug Use and Drug Led HIV in Nepal Bijay Pandey Recovering Nepal.
Financing the response to HIV in low- and middle-income countries: how it is affected by the economic crisis? Robert Greener July 20, 2011.
IAS Members Working Together for a Stronger Health Workforce IAS General Members and Policy Meeting Sydney, 24 th July 2007.
Gender and Development Effectiveness. Entry points for Tanzania? DPG Main, 8 May 2012 Anna Collins-Falk, Representative, UN Women on behalf of DPG Gender.
Debbi Birx, MD PEPFAR/CDC WORKSHOP - Mini Room 7 Center for Global Health Division of Global HIV/AIDS Getting to Six Million PEPFAR Track 1.0 Treatment.
Next Steps 1.Addressing Operational Issues of strategic importance 2.Input of AC in process of strategy development 3.Establishing of a functional African.
2009 ECONOMIC AND SOCIAL COUNCIL ANNUAL MINISTERIAL REVIEW HIV in Latin America and the Caribbean Implementing agreed goals and commitments César Antonio.
1 S trengthening accountability for gender equality To learn more visit
Response of Governments/International Institutions/Civil Society on Scaling Up HIV/AIDS Financing Global Conference Brasilia, Brazil – November 2006 Aisha.
BACKGROUND METHODOLOGY & SAMPLE SPECIFICATIONS THE SURVEY QUESTIONS SUMMARY OF THE FINDINGS PRESENTATION OF THE RESULTS Content of report.
Stigma & Discrimination: The Undoing of Universal Access?? Dr Mandeep Dhaliwal International HIV/AIDS Alliance Lawyers Collective HIV/AIDS Unit PARA 55.
Setting Standards for Health Statistics: The HMN Framework High Level Forum on Strategic Planning for Statistics Bangkok 6-9 June
Supporting community action on AIDS in developing countries Costing Community Mobilization: An NGO Perspective Jason Taylor Wright, MSFS, MA U.S. Director.
UNAIDS Program Coordinating Board Meeting 10 December 2009 Geneva The Impact of the Global Economic Crisis on HIV and AIDS.
1 Domestic Financing for Health Parliamentarian Round Table March 2014,Joburg, SA Linda Mafu, Head Political Advocacy and Civil Society Department,
Securing the future today Synthesis of strategic information on HIV and young people Global Interagency Task Team on HIV and young people, June 2011.
International HIV Assistance from Donor Governments: Disbursements, US$ Billions.
IATT Advocacy Working Group April 15, Purpose and Members Objectives Influence decision-making by providing support to establish new or change existing.
Regional Videoconference Addressing Stigma and Discrimination of HIV/AIDS in Africa Thursday, April 2, 2009 UNAIDS Perspective Susan Timberlake, Senior.
The Millennium Development Goals The fight against global poverty and inequality.
Is AIDS Financing dying in Asia ? Swarup Sarkar Senior Adviser, UNAIDS, Geneva ICAAP, Busan, August 2010.
1 |1 | Health system strengthening for Universal Health Coverage and Health systems resilience Health system strengthening for Universal Health Coverage.
Resource Availability for HIV/AIDS & the Funding Gap Juan-Pablo Gutierrez, Stefano Bertozzi National Institute of Public Health National Institute of Public.
Efficiency, Effectiveness, and Financial Sustainability: The Importance of Country Ownership Dr Bernhard Schwartländer UNAIDS.
Getting more value for money: working with countries and partners toward greater effectiveness and efficiency Peter Stegman, Senior Economist.
MDG 6: Combat HIV/AIDS and other diseases. Where are we…  Regionally, “on track” for MDG-6 (only a few countries are progressing slowly or show no progress)
PEPFAR The Global Fund and PEPFAR: Strategic Collaboration for Greater Impact Mark Edington, Director, Grants Management, Global Fund Julia Martin, Chief.
Making smart decisions to end AIDS – an investment approach Mariângela Simão Rights, Gender and Community Mobilization Department.
The Bank’s Regional HIV/AIDS Strategies An Overview.
International Aid Towards HIV/AIDs in sub-Saharan Africa Ally H. Van Valen.
33 MEETING OF THE UNAIDS PROGRAMME COORDINATING BOARD GENEVA, SWITZERLAND DECEMBER 2013 THE EQUITY DEFICIT: UNEQUAL AND UNFAIR ACCESS TO HIV TREATMENT,
The HIV Response Where are we now?
20:20 Vision Making new and old money work better
Fabienne Hariga Senior Adviser, HIV/AIDS Section
Sustainable Community Based Rehabilitation at local and national levels Presented by Professor Gwynnyth Llewellyn (University of Sydney) and Darryl Barrett.
The global state of harm reduction funding
Incorporating transition considerations into the new Global Fund funding cycle Mauro Guarinieri Senior Technical Adviser, Community Responses and Drug.
Total Estimated Available Resources for HIV from All Sources
Nebojša Đurasović Vilnius, April 2017.
The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002–2014)  Jamie Bridge,
HIV Response Funding Trends 10:30 am to 12:00 pm
AIDS: the long term view Peter Piot
Module 5 SDG follow-up and review mechanisms
UK role in Statistical Capacity Building
Antiretroviral therapy coverage in sub-Saharan Africa,
Showing throughout the event
Morris Edwards Nadia Liu
Strategies for sustainable financing of harm reduction:
Key Affected Populations
From "nice-to-have" to "necessary": Increases in domestic financing and the perceived value of key population-led HIV services by the Thai government.
Presentation transcript:

Is harm reduction funding in low and middle income countries in crisis? Susie McLean, International HIV/AIDS Alliance Catherine Cook, Harm Reduction International Jamie Bridge, International Drug Policy Consortium

‘ Given the severity of the challenge, HIV prevention programming for people who inject drugs is badly under-resourced’ UNAIDS

Harm reduction – low coverage 3

Harm reduction – how much money is needed? 4

Difficult to know Government reports to UNAIDS don’t disaggregate International donors not making investment information available Differences in budget disaggregation Harm reduction – how much is being spent? 5

National governments Domestic investment in HIV is increasing BUT investment in harm reduction not reflected in this trend Priority countries: less than 5% of HIV investment Harm reduction – how much is being spent? 6

The political unpopularity of harm reduction 7

Harm reduction – dependent on international donors 8

People who inject drugs and the need for harm reduction – in middle income countries 9

Global Fund investments in harm reduction R1-R10 (2002 – 2010) 10

58 countries have received $ for harm reduction previously 41% (24) now ineligible or will receive no new $ Only 10 countries (5 MIC) are eligible for ‘incentive funding’ or funding for ‘critical enablers’ More than half MICs “over- allocated” Downward trend? Global Fund New Funding Model – bad news for harm reduction? 11

DFID bilateral funding for harm reduction - reducing dramatically Australian Government funding - unknown Dutch Government funding – maintaining their commitment PEPFAR funding – national ownership and technical support rather than programming International donor trends – away from harm reduction 12

PEPFAR spending on HIV prevention for people who use drugs in Analysis on PEPFAR spending conducted by George Washington University in 2013, commissioned by AmfAR (unpublished) 13

1. Keep the Global Fund global 14 New indicators to determine allocations –Inequalities –Willingness to pay –Policy barriers –Transitions to domestic funding Fully funded Global Fund no-one left behind

International donors -Invest where national governments won’t/can’t -Responsible exit strategies -Influence national governments UN agencies -Improve data on harm reduction need, coverage and investment 2. Invest strategically in harm reduction 15

National governments: Fund national harm reduction programmes -sustainability Address stigma related to HIV & drug use -public debate -attitudes of decision makers 3. Increase national harm reduction investment 16

National governments: -Cost effectiveness analyses. Is drug control value for money? -Estimate resource needs for HIV and harm reduction and rebalance towards health International donors: - Work together to define and commit to an international target for harm reduction investment Rebalance resources From drug control and criminalisation to health and harm reduction 17

18